TWOEquity · Weekly research terminal

1796

GeneFerm Biotechnology Co., Ltd.

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
14 Aug 2026
Weekly close
30.70 TWD
Fair value
52.18 TWD
Next-week expectancy
Negative 36.28%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

1796

GeneFerm Biotechnology Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well as probiotics and …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
1,272,815,616
Fair value reference
52.18
Next-week expectancy
Negative · 36.28%

Over the latest 12 completed weeks ending 2026-08-14, 1796 fell 12.63%, moving from 35.14 to 30.70. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -50.48 and has improved across the 12-week window. Market Dynamics is -1.18 on the latest week. Next-week expectancy is negative at 36.28% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
30.70
12-Week Change
-12.63%
Trend Signal
Inactive
Next-Week Expectancy
Negative 36.28%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
30.70
12-Week Change
-12.63%
Trend Signal
Inactive
Next-Week Expectancy
Negative 36.28%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-50.48
Market Dynamics
-1.18

Over the latest 12 completed weeks ending 2026-08-14, 1796 fell 12.63%, moving from 35.14 to 30.70. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -50.48 and has improved across the 12-week window. Market Dynamics is -1.18 on the latest week. Next-week expectancy is negative at 36.28% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 14 Aug 2026 1200.00 1550.00 1190.00 1500.00 25.00%
6932 Merdury Biopharmaceutical Corporation TWO 14 Aug 2026 5.13 8.63 5.01 6.02 17.35%
7829 Yoda Pharmaceuticals Inc. TWO 14 Aug 2026 39.85 46.35 39.85 44.90 12.67%
4747 Johnson Chemical Pharmaceutical Works Co., Ltd. TWO 14 Aug 2026 49.70 58.10 49.70 54.50 9.66%
6467 TAHO Pharma TWO 14 Aug 2026 114.00 130.00 114.00 125.00 9.65%
6621 UniPharma Co., Ltd. TWO 14 Aug 2026 11.00 11.95 10.60 11.65 5.91%
6539 DV Biomed Co., Ltd. TWO 14 Aug 2026 40.30 42.40 38.30 42.40 5.21%
4172 InnoPharmax Inc. TWO 14 Aug 2026 10.95 11.45 10.70 11.45 4.57%
1780 Allied Biotech Corporation TWO 14 Aug 2026 22.75 23.75 22.30 23.75 4.40%
6483 Original BioMedicals Co., Ltd. TWO 14 Aug 2026 13.50 14.10 13.50 14.05 4.07%
6785 Alar Pharmaceuticals Inc. TWO 14 Aug 2026 98.10 104.00 96.50 100.00 1.94%
4114 Synmosa Biopharma Corporation TWO 14 Aug 2026 29.30 30.15 29.05 29.80 1.71%
3705 YungShin Global Holding Corporation TAI 14 Aug 2026 53.50 54.50 53.00 54.30 1.50%
7860 TEH SENG TWO 14 Aug 2026 71.20 74.00 68.50 72.00 1.12%
4108 PhytoHealth Corporation TAI 14 Aug 2026 11.15 11.25 10.90 11.25 0.90%
6576 Foresee Pharmaceuticals Co., Ltd. TWO 14 Aug 2026 79.00 80.70 78.70 79.70 0.89%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context